Scarica l'app Stockscreener
13.36
0.68%
0.09
Pre-mercato:
13.16
-0.20
-1.50%
Precedente Chiudi:
$13.27
Aprire:
$13.16
Volume 24 ore:
151.38K
Relative Volume:
1.26
Capitalizzazione di mercato:
$4.03B
Reddito:
$391.87M
Utile/perdita netta:
$-441.45M
Rapporto P/E:
-7.2216
EPS:
-1.85
Flusso di cassa netto:
$-301.21M
1 W Prestazione:
+0.38%
1M Prestazione:
+12.17%
6M Prestazione:
+11.89%
1 anno Prestazione:
-5.52%
Intervallo 1D:
$13.05
$13.44
Intervallo di 1 settimana:
$13.05
$13.50
Portata 52W:
$9.15
$18.00
Alvotech Stock (ALVO) Company Profile
Confronta ALVO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ALVO
Alvotech
|
13.36 | 4.03B | 391.87M | -441.45M | -301.21M | -1.85 |
|
ZTS
Zoetis Inc
|
167.53 | 75.58B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.24 | 41.78B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.10 | 41.53B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
21.82 | 24.72B | 16.77B | -959.00M | 1.37B | -0.85 |
|
NBIX
Neurocrine Biosciences Inc
|
145.88 | 14.77B | 2.24B | 385.90M | 440.10M | 3.73 |
Alvotech Stock (ALVO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-01-29 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2023-10-20 | Aggiornamento | Citigroup | Sell → Neutral |
| 2023-09-21 | Iniziato | Barclays | Equal Weight |
| 2022-09-07 | Iniziato | Morgan Stanley | Equal-Weight |
| 2022-09-06 | Downgrade | Citigroup | Buy → Sell |
| 2022-07-26 | Iniziato | Citigroup | Buy |
Mostra tutto
Alvotech Borsa (ALVO) Ultime notizie
JB Hunt Transport Posts Weak Earnings, Joins JetBlue Airways And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga
Why Versus Systems Shares Are Trading Higher By Around 71%; Here Are 20 Stocks Moving Premarket - Benzinga
Alvotech : Transactions of Managers and Closely Associated Persons - Marketscreener.com
Has Alvotech (ALVO) Outpaced Other Medical Stocks This Year? - Yahoo Finance
Alvotech (NASDAQ:ALVO) Sees Large Growth in Short Interest - MarketBeat
Alvotech (NASDAQ:ALVO) Shares Gap UpWhat's Next? - MarketBeat
Alvotech birtir fjárhagsdagatal fyrir árið 2025 - GlobeNewswire
Alvotech Eyes Growth As Product Revenue Soars And New Launches ApproachWill The Stock Follow? - RTTNews
Are Medical Stocks Lagging Alvotech (ALVO) This Year? - Yahoo Finance
Alvotech (NASDAQ:ALVO) Short Interest Update - MarketBeat
Alvotech Joins Nasdaq Biotechnology Index, Boosting Industry Presence - TipRanks
Alvotech : Added to Nasdaq Biotech Index Effective Monday December 23, 2024 Form 6 K - Marketscreener.com
Alvotech Added to Nasdaq Biotech Index Effective Monday December 23, 2024 - The Manila Times
Alvotech Secures Coveted Spot in Nasdaq Biotechnology Index Following Strong Market Performance - StockTitan
ALVOAlvotech Ordinary Shares Latest Stock News & Market Updates - StockTitan
Wall Street Analysts Believe Alvotech (ALVO) Could Rally 39.83%: Here's is How to Trade - MSN
Alvotech's SWOT analysis: biosimilar powerhouse stock faces b2b model challenges - Investing.com
Is Alvotech (ALVO) Stock Outpacing Its Medical Peers This Year? - MSN
Eye on Pharma: Golimumab Biosimilar Update; Korea Approves Denosumab; Xbrane, Intas Collaboration - The Center for Biosimilars
Alvotech (NASDAQ:ALVO) Is Expected To Breakeven In The Near Future - Simply Wall St
Short Interest in Alvotech (NASDAQ:ALVO) Rises By 47.8% - MarketBeat
Alvotech’s Eylea Biosimilar ‘Keeps In Mind’ US Patent Landscape - Citeline
Alvotech's SWOT analysis: biosimilars powerhouse stock faces growth hurdles - Investing.com
Alvotech (ALVO) Shares Gap Down to $11.94 on Nov 22 - GuruFocus.com
Are Medical Stocks Lagging CareCloud (CCLD) This Year? - Yahoo Finance
Alvotech’s Position In The Coming Biosimilar Gold Rush (NASDAQ:ALVO) - Seeking Alpha
Alvotech (ALVO) Q3 Earnings and Revenues Beat Estimates - MSN
Alvotech Third Quarter 2024 Earnings: US$0.041 loss per share (vs US$0.81 loss in 3Q 2023) - Yahoo Finance
Earnings call: Alvotech reported revenues of $128 million - Investing.com India
Alvotech (ALVO) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Advancements - Investing.com Canada
Alvotech Reports Strong Revenue Growth in 2024 - TipRanks
Earnings call: Alvotech reported revenues of $128 million By Investing.com - Investing.com Canada
Alvotech earnings missed, revenue fell short of estimates By Investing.com - Investing.com Nigeria
Alvotech earnings missed, revenue fell short of estimates - Investing.com India
Alvotech's SWOT analysis: biosimilars powerhouse stock faces growth challenges By Investing.com - Investing.com Australia
Alvotech : First 9 Months Earnings and Business Update 2024 - Marketscreener.com
Alvotech Showcases Strong Financial Growth and Expansion - TipRanks
Alvotech Reports Financial Results for the First Nine Months of 2024 - The Manila Times
Alvotech's SWOT analysis: biosimilars powerhouse stock faces growth challenges - Investing.com
EMA Accepts Marketing Authorization Application for Alvotech’s AVT05 (golimumab) - JD Supra
Alvotech Attending Citi's Global Healthcare Conference on December 4, 2024, and Evercore's HealthCONx Conference on December 5, 2024 - The Manila Times
Alvotech Attending Citi's Global Healthcare Conference on - GlobeNewswire
Alvotech to Present at Citi and Evercore Healthcare Conferences in December | ALVO Stock News - StockTitan
Alvotech Azioni (ALVO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.14%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):